NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered GHK-Cu from LiliPeptide? Mail in a sample (US only) and let us test it.

Test my supply
+7 more ↓
94%
Finnrick rating
#3 of 156 GHK-Cu vendors
27 of 28 classifiable tests passed
customers 4.8★ (22)
methodology · Purity focus
Finnrick analysis · GHK-Cu

Batch-ID gaps and fill swings are the main caveats for LiliPeptide GHK-Cu despite strong purity-focused results. One vial missed at 99.2% purity; otherwise identity/purity passed, while fills ranged -31% to +17%.

methodology →
vendor intelligence report
Vendor Intelligence Report: LiliPeptide

Corporate and domain records point to a China/Hong Kong sales network behind the U.S.-listed storefront, with the typo domain, Peptide-Sources and ElitePeptide66 tied by reused policy text. The report maps batchless COAs, Nuoao template artifacts and post-payment fee complaints.

37 pages8 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cuselected
$0.06
94%
28
2
Tirzepatide
$0.53
82%
44
3
Retatrutide
$0.97
80%
157
4
SS-31
$1.15
77%
3
5
PT-141
$0.40
69%
10
6
BPC-157
$0.70
68%
24
7
Ipamorelin
$0.95
64%
10
8
Tesamorelin
$2.45
56%
24
9
Melanotan II
$0.55
56%
5
10
Cagrilintide
$25.00
54%
4
11
CJC-IPA
-
44%
1
12
MOTS-c
$0.80
37%
9
13
NAD+
$0.02
26%
4
14
CJC-1295
$2.05
25%
6
15
TB-500
$1.55
22%
15
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%25 Sep 2025: 86%3 Oct 2025: 88%4 Nov 2025: 90%25 Nov 2025: 89%25 Nov 2025: 90%6 Dec 2025: 91%17 Dec 2025: 92%17 Dec 2025: 92%17 Dec 2025: 93%15 Jan 2026: 94%26 Jan 2026: 94%9 Feb 2026: 94%20 Feb 2026: 95%20 Feb 2026: 96%22 Feb 2026: 96%26 Feb 2026: 96%1 Mar 2026: 96%2 Mar 2026: 97%18 Mar 2026: 93%21 Mar 2026: 93%28 Apr 2026: 93%18 May 2026: 94%1 Jun 2026: 94%2 Jun 2026: 94%16 Jun 2026: 94%9 Aug 2026: 94%21 Aug 2026: 94%15 Sep 2026: 94%15 Nov 2026: current 94%86%95%94%Sep 25Nov 26
Showing GHK-Cu tests only
Peptide testing

Ordered GHK-Cu from LiliPeptide? Mail in a sample (US only) and let us test it.

Test my supply
LiliPeptide GHK-Cu test history
COA-backed lab tests
1-10 of 28

About LiliPeptide test results from Finnrick

LiliPeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 15 peptides and 344 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible LiliPeptide peptides in this dataset are BPC-157 (24 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.
Peptide testing

Ordered GHK-Cu from LiliPeptide? Mail in a sample (US only) and let us test it.

Test my supply